Intuitive Surgical, Inc.

Key Statistics

Recent News

• FDA Scrutiny Puts Intuitive Surgical Staplers And Growth Story Under Pressure Simply Wall St.

  FDA safety alerts and voluntary recalls tied to Intuitive Surgical stapler reloads have brought fresh regulatory focus to the da Vinci platform. The issues relate to certain da Vinci S and Si instrume

• The Zacks Analyst Blog Highlights Mastercard, Seagate, Intuitive Surgical, Monarch Cement and Canterbury Park Zacks

  Mastercard, Seagate and Intuitive Surgical lead Zacks' featured reports as AI demand, payments growth and procedure expansion shape outlooks.

• Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know Zacks

  Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.

• Top Stock Reports for Mastercard, Seagate & Intuitive Surgical Zacks

  Mastercard, Seagate and Intuitive Surgical headline new research reports, highlighting growth drivers, outlooks and key challenges shaping performance.

• Is Intuitive Surgical, Inc. (ISRG) A Good Stock To Buy Now? Insider Monkey

  Is ISRG a good stock to buy? We came across a bullish thesis on Intuitive Surgical, Inc. on r/investing_discussion by Variant_Invest. In this article, we will summarize the bulls’ thesis on ISRG. Intu

• Intuitive Surgical, Inc. (ISRG) Rises As Market Takes a Dip: Key Facts Zacks

  In the most recent trading session, Intuitive Surgical, Inc. (ISRG) closed at $426.61, indicating a +1.91% shift from the previous trading day.

• How The Intuitive Surgical (ISRG) Narrative Is Shifting With Reset Valuations And Mixed Analyst Views Simply Wall St.

  Intuitive Surgical’s fair value estimate has been reset from US$611.82 to US$565.25, signaling a lower price target that analysts are now using in their models. This shift lines up with recent researc

• Intuitive Surgical (ISRG) Upgraded to Buy: Here's Why Zacks

  Intuitive Surgical (ISRG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.